Fuso Chemical
4368.TChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥76.9bn | ¥69.5bn | ¥59.0bn | ¥68.5bn | ¥55.8bn | ¥42.2bn |
| Operating income | ¥18.9bn | ¥16.2bn | ¥11.1bn | ¥18.9bn | ¥15.0bn | ¥9.6bn |
| Ordinary income | ¥19.6bn | ¥16.6bn | ¥11.9bn | ¥19.7bn | ¥15.5bn | ¥9.7bn |
| Net income (owners) | ¥14.3bn | ¥11.6bn | ¥8.3bn | ¥14.1bn | ¥10.9bn | ¥6.8bn |
| Total assets | ¥152.3bn | ¥141.5bn | ¥133.7bn | ¥113.5bn | ¥92.0bn | ¥76.0bn |
| Net assets / equity | ¥117.2bn | ¥104.0bn | ¥95.0bn | ¥87.5bn | ¥75.3bn | ¥66.2bn |
| Operating cash flow | ¥24.8bn | ¥22.7bn | ¥7.1bn | ¥13.9bn | ¥10.2bn | ¥12.8bn |
| EPS (basic) | ¥135.28 | ¥109.89r | ¥78.9r | ¥133.63r | ¥102.69r | ¥191.75 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 15
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 203 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 71 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 203 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
| 2023-04-01 → 2024-03-31 | AnnualAmended | 203 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 203 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 73 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 71 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 203 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 203 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 73 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 71 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 203 figures · EDINET |
23 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Electronic Materials Business Unit | ¥41.5bn | ¥15.9bn |
| Life Science Business Unit | ¥35.4bn | ¥5.3bn |
| Adjustments & eliminations | — | −¥2.4bn |
| Total | ¥76.9bn | ¥21.2bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.